CrossrefInfokarte
A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins
Neuropsychiatric Disease and Treatment · 2011-12 · 13
DOI: 10.2147/ndt.s16085 ↗Abstract
Kein Abstract verfügbar.
EUVIMED